Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Colloquium Supported by Eisai Europe Ltd.: Optimising outcomes of patients with advanced renal cancer

The emerging continuum of care in advanced RCC: Second-line and beyond

Date

11 Sep 2022

Session

ESMO Colloquium Supported by Eisai Europe Ltd.: Optimising outcomes of patients with advanced renal cancer

Topics

Targeted Therapy;  Immunotherapy

Tumour Site

Renal Cell Cancer

Presenters

Camillo Guglielmo Porta

Authors

C.G. Porta

Author affiliations

  • Biomedical Sciences And Human Oncology, Università degli Studi di Bari Aldo Moro, 70121 - Bari/IT
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.